Nothing Special   »   [go: up one dir, main page]

ATE263242T1 - Aminoterminal verkürztes rantes als chemokin antagonist - Google Patents

Aminoterminal verkürztes rantes als chemokin antagonist

Info

Publication number
ATE263242T1
ATE263242T1 AT98951476T AT98951476T ATE263242T1 AT E263242 T1 ATE263242 T1 AT E263242T1 AT 98951476 T AT98951476 T AT 98951476T AT 98951476 T AT98951476 T AT 98951476T AT E263242 T1 ATE263242 T1 AT E263242T1
Authority
AT
Austria
Prior art keywords
aminoterminal
rantes
shortened
chemokine antagonist
chemokine
Prior art date
Application number
AT98951476T
Other languages
English (en)
Inventor
Paul Proost
Sofie Struyf
Damme Jo Van
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE263242(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE263242T1 publication Critical patent/ATE263242T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98951476T 1997-09-29 1998-09-28 Aminoterminal verkürztes rantes als chemokin antagonist ATE263242T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP97116863A EP0906954A1 (de) 1997-09-29 1997-09-29 Aminoterminalen verkürzten C-C Chemokine als Chemokine Antagonist
EP97122471A EP0905240A1 (de) 1997-09-29 1997-12-19 Aminoterminalen verkürzten C-C-chemokine and als chemokine Antagonist
EP98104216A EP0905241A1 (de) 1997-09-29 1998-03-10 Aminoterminalen verkürzten C-C Chemokine und als Chemokine Antagonist
PCT/EP1998/006143 WO1999016877A1 (en) 1997-09-29 1998-09-28 Amino-terminally truncated rantes as chemokine antagonists

Publications (1)

Publication Number Publication Date
ATE263242T1 true ATE263242T1 (de) 2004-04-15

Family

ID=8227408

Family Applications (3)

Application Number Title Priority Date Filing Date
AT98951476T ATE263242T1 (de) 1997-09-29 1998-09-28 Aminoterminal verkürztes rantes als chemokin antagonist
AT04007579T ATE368742T1 (de) 1997-09-29 1998-09-28 Aminoterminalen verkürzten c-c chemokine und als chemokine antagonist
AT98947553T ATE264390T1 (de) 1997-09-29 1998-09-28 Aminoterminal verkürztes mcp-2 als chemokin antagonist

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT04007579T ATE368742T1 (de) 1997-09-29 1998-09-28 Aminoterminalen verkürzten c-c chemokine und als chemokine antagonist
AT98947553T ATE264390T1 (de) 1997-09-29 1998-09-28 Aminoterminal verkürztes mcp-2 als chemokin antagonist

Country Status (29)

Country Link
US (5) US6905676B2 (de)
EP (6) EP0906954A1 (de)
JP (2) JP4233214B2 (de)
KR (2) KR100560275B1 (de)
CN (3) CN1233415C (de)
AR (2) AR013528A1 (de)
AT (3) ATE263242T1 (de)
AU (2) AU750341B2 (de)
BG (2) BG64757B1 (de)
BR (2) BR9812394A (de)
CA (2) CA2305017A1 (de)
CY (1) CY1110927T1 (de)
CZ (2) CZ299479B6 (de)
DE (3) DE69822856T2 (de)
DK (3) DK1021541T3 (de)
EA (2) EA003942B1 (de)
EE (2) EE200000151A (de)
ES (3) ES2218860T3 (de)
HK (3) HK1032425A1 (de)
HU (2) HU226468B1 (de)
IL (2) IL135351A (de)
NO (2) NO20001584D0 (de)
NZ (3) NZ503235A (de)
PL (2) PL196427B1 (de)
PT (3) PT1021541E (de)
SK (2) SK286439B6 (de)
UA (2) UA73080C2 (de)
WO (2) WO1999016877A1 (de)
ZA (2) ZA988675B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
AU1616499A (en) * 1997-12-01 1999-06-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Chemokine variants and methods of use
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
EP1167527A1 (de) * 2000-06-22 2002-01-02 Euroscreen S.A. Prozessierte Menschliche Chemokine: PHC-1 und PHC-2
ES2272329T3 (es) * 1999-10-25 2007-05-01 Pharis Biotec Gmbh Quimioquinina humana phc-1 procesada.
AU2505601A (en) * 1999-11-15 2001-05-30 Wolf-Georg Forssmann Novel use of hcc-2
CA2316405A1 (en) * 2000-05-26 2001-11-26 Ian Clark-Lewis Modulation of inflammation by protease products
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
GB2373785A (en) * 2001-03-28 2002-10-02 Rega Inst For Medical Res Truncating chemokines using dipeptidyl peptidase IV
IL162600A0 (en) 2001-12-17 2005-11-20 Applied Research Systems Cc-chemokine mutants as cc-chemokine antagonists
WO2004104216A2 (en) * 2003-05-21 2004-12-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
DE102005049637A1 (de) * 2005-10-14 2007-04-26 Rheinisch-Westfälische Technische Hochschule Aachen Antagonisten gegen die Interaktion von PF4 und RANTES
JP5624884B2 (ja) 2007-08-02 2014-11-12 ノビミューンエスアー 抗ｒａｎｔｅｓ抗体およびその使用の方法
WO2011097567A1 (en) * 2010-02-08 2011-08-11 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Rantes multiplexed assay, rantes variants related to disease, and rantes variants related to enzymatice activity
EP2545174B1 (de) 2010-03-11 2015-11-11 Health Research, Inc. Verfahren und zusammensetzungen mit fc-fusionsproteinen zur verstärkung von immunreaktionen
TW201718851A (zh) * 2015-09-18 2017-06-01 通用醫院公司 具有抗化學排斥(anti-fugetactic)性質之經修飾自然殺手細胞及其用途
CA3101052A1 (en) 2018-05-28 2019-12-05 ORION Biotechnology Switzerland Sarl Methods of inhibiting cerebral inflammation
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
US11402391B2 (en) 2020-12-21 2022-08-02 Incelldx, Inc. Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0311107A3 (de) 1987-10-08 1990-04-18 Stichting REGA V.Z.W. Anti-HIV-aktive 3'-Fluoro-purin-2',3'-dideoxyriboside
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
NZ296570A (en) * 1994-12-08 1998-11-25 Glaxo Group Ltd Anti-inflammatory peptides related to rantes
WO1997025427A1 (en) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mcp-2)
WO1997035982A2 (en) * 1996-03-27 1997-10-02 Icos Corporation Monocyte chemotactic protein-5 materials and methods
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
US6168784B1 (en) * 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use

Also Published As

Publication number Publication date
PT1019507E (pt) 2004-06-30
DE69838188T2 (de) 2007-11-22
US7326411B2 (en) 2008-02-05
US20030124677A1 (en) 2003-07-03
EP1439231A3 (de) 2004-12-22
WO1999016876A1 (en) 1999-04-08
HUP0003505A2 (hu) 2001-02-28
EA003942B1 (ru) 2003-10-30
SK286495B6 (sk) 2008-11-06
BR9812394A (pt) 2000-09-12
UA73081C2 (en) 2005-06-15
NZ516027A (en) 2003-05-30
JP4230659B2 (ja) 2009-02-25
DK1021541T3 (da) 2004-08-02
BG104267A (en) 2000-11-30
CN1233415C (zh) 2005-12-28
ATE264390T1 (de) 2004-04-15
EP0905240A1 (de) 1999-03-31
AU9442098A (en) 1999-04-23
PT1439231E (pt) 2007-08-20
PL197569B1 (pl) 2008-04-30
EP1439231B1 (de) 2007-08-01
BG64679B1 (bg) 2005-11-30
US20050164936A1 (en) 2005-07-28
IL135351A (en) 2006-08-20
EE200000151A (et) 2001-02-15
ES2287601T3 (es) 2007-12-16
US6905676B2 (en) 2005-06-14
US20050220790A1 (en) 2005-10-06
JP4233214B2 (ja) 2009-03-04
CA2304827A1 (en) 1999-04-08
AR013528A1 (es) 2000-12-27
CZ299478B6 (cs) 2008-08-06
PL196427B1 (pl) 2008-01-31
HK1032425A1 (en) 2001-07-20
HU226468B1 (en) 2008-12-29
AR013529A1 (es) 2000-12-27
PL339545A1 (en) 2000-12-18
IL135352A (en) 2006-08-20
EP0906954A1 (de) 1999-04-07
EP1019507B1 (de) 2004-03-31
ES2215324T3 (es) 2004-10-01
EA200000379A1 (ru) 2000-10-30
ATE368742T1 (de) 2007-08-15
US7338653B2 (en) 2008-03-04
PT1021541E (pt) 2004-07-30
CN1271386A (zh) 2000-10-25
BG104266A (en) 2000-11-30
SK4512000A3 (en) 2000-09-12
JP2001518297A (ja) 2001-10-16
ZA988676B (en) 1999-12-03
NO20001609D0 (no) 2000-03-28
HK1062637A1 (en) 2004-11-19
EE200000152A (et) 2001-02-15
CZ20001146A3 (cs) 2000-09-13
KR20010024213A (ko) 2001-03-26
ZA988675B (en) 1999-11-24
HUP0003563A3 (en) 2005-11-28
US20030119148A1 (en) 2003-06-26
KR20010024214A (ko) 2001-03-26
US6977071B2 (en) 2005-12-20
KR100542934B1 (ko) 2006-01-11
DE69823218D1 (de) 2004-05-19
SK286439B6 (sk) 2008-10-07
HU226414B1 (en) 2008-11-28
CN1271385A (zh) 2000-10-25
SK4502000A3 (en) 2000-09-12
WO1999016877A1 (en) 1999-04-08
CN1148447C (zh) 2004-05-05
AU9747498A (en) 1999-04-23
PL339559A1 (en) 2000-12-18
EP0905241A1 (de) 1999-03-31
DE69838188D1 (de) 2007-09-13
HUP0003505A3 (en) 2005-11-28
BR9812565A (pt) 2000-08-01
EA003940B1 (ru) 2003-10-30
NZ503234A (en) 2002-06-28
EP1439231A2 (de) 2004-07-21
DK1439231T3 (da) 2007-11-05
DE69823218T2 (de) 2004-08-26
CN1490049A (zh) 2004-04-21
ES2218860T3 (es) 2004-11-16
CN1145693C (zh) 2004-04-14
EA200000378A1 (ru) 2000-10-30
NO20001584L (no) 2000-03-27
EP1021541B1 (de) 2004-04-14
US20050201977A1 (en) 2005-09-15
DK1019507T3 (da) 2004-07-19
CZ20001147A3 (cs) 2000-09-13
CZ299479B6 (cs) 2008-08-06
KR100560275B1 (ko) 2006-03-10
DE69822856D1 (de) 2004-05-06
CY1110927T1 (el) 2015-06-10
NO20001609L (no) 2000-03-28
EP1021541A1 (de) 2000-07-26
JP2001518296A (ja) 2001-10-16
DE69822856T2 (de) 2004-08-19
HK1032426A1 (en) 2001-07-20
NZ503235A (en) 2002-08-28
UA73080C2 (en) 2005-06-15
EP1019507A1 (de) 2000-07-19
CA2305017A1 (en) 1999-04-08
AU750341B2 (en) 2002-07-18
AU750606B2 (en) 2002-07-25
NO20001584D0 (no) 2000-03-27
HUP0003563A2 (hu) 2001-02-28
BG64757B1 (bg) 2006-02-28

Similar Documents

Publication Publication Date Title
ATE263242T1 (de) Aminoterminal verkürztes rantes als chemokin antagonist
BR9509997A (pt) Antagonista de taquiquinina
DE69719354D1 (de) Muscarin-antagonisten
DE69431604D1 (de) Benzofuranderivate als tachykininantagonisten
PT738150E (pt) Antagonistas biciclicos de fibrinogenio
DE59813430D1 (de) Perylenhydrazidimide als Carbonylderivatisierungsreagenzien
ATE232526T1 (de) 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten
DE69622731D1 (de) Tetrahydrochinoline als nmda antagonisten
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
ATE240954T1 (de) Oxazolidinone als 5-ht2a-antagonisten
ATE290546T1 (de) Tachykinin antagoniste
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
NO179550C (no) Tachykinin reseptorantagonister
DE69826129D1 (de) Quaternäre ammoniumverbindungen als tachykinin antagonisten
FI941118A (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
DE59407285D1 (de) Imidazolochinoxalinonderivate als eaa antagonisten
KR950027351U (ko) 반목 항타장치
IL135351A0 (en) Truncated rantes as chemokine antagonist
DK0964867T3 (da) Tachykininantagonister
KR970702876A (ko) 뉴로키닌 길항제(Neurokinine (tachykinine) antagonists)
SE9702957D0 (sv) Antivirals
KR970055867U (ko) 브이씨알의 메인베이스 보강구조
KR960020587U (ko) 이동식 공구대
KR970704729A (ko) 타키키닌 길항물질로서의 락탐(azetidin-1-ylalkyl lactams as tachykinen antagonists)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1019507

Country of ref document: EP

EEFA Change of the company name